Skip to content
Screener

Pelthos Therapeutics PTHS Q2 2025 earnings

Reported August 13, 2025 · Before market open

Revenue-
EPS-$5.38Miss by $2.28
EPS estimate-$3.10

Next report

Nov 12, 2026 (in 2 months)
Revenue estimate$18.0M
EPS estimate-$2.90

Financials

Q2 2025

Income statement

See full
Revenue-—
Gross profit-—
Operating income-$3.2M-83.1%
Net income-$3.4M-94.7%

Balance sheet

See full
Cash & equivalents$59.2K-97.5%
Total equity-$6.5M-3,429%
Total assets$822.9K-68.4%

Cash flow

See full
Operating cash flow-$447.3K+84.9%

FAQ

When did Pelthos Therapeutics report Q2 2025 earnings?
Pelthos Therapeutics (PTHS) reported Q2 2025 earnings on August 13, 2025 before market open.
What were Pelthos Therapeutics's Q2 2025 revenue and EPS?
Pelthos Therapeutics reported revenue of - and eps of $-5.38 for Q2 2025.
Did Pelthos Therapeutics beat estimates in Q2 2025?
EPS missed the consensus estimate of $-3.10 by $2.28.
Where can I find Pelthos Therapeutics's Q2 2025 SEC filings?
You can read the 10-Q periodic report (0001753926-25-001326) directly on SEC EDGAR. The filing index links above go to sec.gov.